WallStreetZenWallStreetZen

NASDAQ: VIRI
Virios Therapeutics Inc Stock

$0.21+0.03 (+16.67%)
Updated May 24, 2024
VIRI Price
$0.21
Fair Value Price
$0.18
Market Cap
$4.02M
52 Week Low
$0.16
52 Week High
$2.42
P/E
-0.8x
P/B
1.52x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$5.07M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.22
Operating Cash Flow
-$4M
Beta
0.87
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

VIRI Overview

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how VIRI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

VIRI ($0.21) is overvalued by 18.31% relative to our estimate of its Fair Value price of $0.18 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
VIRI ($0.21) is not significantly undervalued (18.31%) relative to our estimate of its Fair Value price of $0.18 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
VIRI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more VIRI due diligence checks available for Premium users.

Be the first to know about important VIRI news, forecast changes, insider trades & much more!

VIRI News

Valuation

VIRI fair value

Fair Value of VIRI stock based on Discounted Cash Flow (DCF)
Price
$0.21
Fair Value
$0.18
Overvalued by
18.88%
VIRI ($0.21) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
VIRI ($0.21) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
VIRI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

VIRI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.8x
Industry
15.58x
Market
32.03x

VIRI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.52x
Industry
6.08x
VIRI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

VIRI's financial health

Profit margin

Revenue
$0.0
Net Income
-$1.3M
Profit Margin
0%
VIRI's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$3.2M
Liabilities
$570.1k
Debt to equity
0.22
VIRI's short-term assets ($3.22M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VIRI's short-term assets ($3.22M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VIRI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$937.4k
Investing
$0.0
Financing
$0.0
VIRI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

VIRI vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
VIRI$4.02M+16.76%-0.80x1.52x
GOVX$4.02M+2.96%-0.12x74.00x
TCON$3.99M-1.97%1.71x-2.27x
ONCO$4.06M+29.08%-0.07x-0.19x
ALZN$4.12M+1.01%-0.32x-0.97x

Virios Therapeutics Stock FAQ

What is Virios Therapeutics's quote symbol?

(NASDAQ: VIRI) Virios Therapeutics trades on the NASDAQ under the ticker symbol VIRI. Virios Therapeutics stock quotes can also be displayed as NASDAQ: VIRI.

If you're new to stock investing, here's how to buy Virios Therapeutics stock.

What is the 52 week high and low for Virios Therapeutics (NASDAQ: VIRI)?

(NASDAQ: VIRI) Virios Therapeutics's 52-week high was $2.42, and its 52-week low was $0.16. It is currently -91.36% from its 52-week high and 33.97% from its 52-week low.

How much is Virios Therapeutics stock worth today?

(NASDAQ: VIRI) Virios Therapeutics currently has 19,257,937 outstanding shares. With Virios Therapeutics stock trading at $0.21 per share, the total value of Virios Therapeutics stock (market capitalization) is $4.02M.

Virios Therapeutics stock was originally listed at a price of $16.71 in Dec 17, 2020. If you had invested in Virios Therapeutics stock at $16.71, your return over the last 3 years would have been -98.75%, for an annualized return of -76.79% (not including any dividends or dividend reinvestments).

How much is Virios Therapeutics's stock price per share?

(NASDAQ: VIRI) Virios Therapeutics stock price per share is $0.21 today (as of May 24, 2024).

What is Virios Therapeutics's Market Cap?

(NASDAQ: VIRI) Virios Therapeutics's market cap is $4.02M, as of May 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Virios Therapeutics's market cap is calculated by multiplying VIRI's current stock price of $0.21 by VIRI's total outstanding shares of 19,257,937.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.